Literature DB >> 22326122

The Gruppo Otologico experience of endolymphatic sac tumor.

Sami Tanbouzi Husseini1, Enrico Piccirillo, Abdelkader Taibah, Carlo T Paties, Tamama Almutair, Mario Sanna.   

Abstract

OBJECTIVE: Endolymphatic sac tumor (ELST) is a rare low grade adenocarcinoma of the skull base. During the past decade the number of the reported cases has increased. This study exposes our experience in the management of ELST with a review of the literature. STUDY
DESIGN: Retrospective study of patients with ELST at a quaternary referral otology and skull base center.
METHODS: A review of the records from the Gruppo Otologico revealed 7 patients treated for ELST. All papers containing series of three or more cases of ELST published in the English literature were selected for analysis.
RESULTS: Hearing loss and tinnitus were present in almost all our cases. All of them were evaluated with audiometric tests, computed tomography and magnetic resonance imaging. All the patients were treated surgically with preservation of the facial nerve and preoperative embolization was performed in 5 patients. Genetic study was performed on all our cases and revealed the presence of von Hippel-Lindau syndrome in one patient who had the tumor as the initial manifestation of his syndrome. None of the patients received postoperative radiotherapy and one of them had recurrence of the tumor 13 years following surgery.
CONCLUSIONS: Complete surgical resection with preoperative embolization of large tumors is the mainstay treatment for ELST. The facial nerve should not be sacrificed unless it is totally invaded by the tumor. A long term follow up is recommended and the role of postoperative adjunctive radiotherapy is still controversial.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22326122     DOI: 10.1016/j.anl.2012.01.009

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  7 in total

1.  The endolymphatic sac tumor: challenges in the eradication of a localized disease.

Authors:  Vittoria Sykopetrites; Gianluca Piras; Annalisa Giannuzzi; Antonio Caruso; Abdelkader Taibah; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-05       Impact factor: 2.503

2.  Treatment of endolymphatic sac tumour (Papillary adenocarcinoma) of the temporal bone.

Authors:  Arturo Mario Poletti; Siba Prasad Dubey; Giovanni Colombo; Giovanni Cugini; Antonio Mazzoni
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-30

3.  Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.

Authors:  E Zanoletti; L Girasoli; D Borsetto; G Opocher; A Mazzoni; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

4.  Endolymphatic Sac Tumor as a Ménière-Like Vertiginous Syndrome: A Case Report.

Authors:  Mario Jesus Villegas-González; Josefina Alejandra Morales-Del Angel; José Luis Treviño González; Daniel Aranda-Garcia; Germán Armando Soto-Galindo; Adriana Miroslava Pérez Peña
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

5.  Endolymphatic sac tumor at the cerebellopontine angle: A case report and review of literature.

Authors:  Afnan Alkhotani; Babar Butt; Mohammad Khalid; Mohammad Binmahfoodh; Youssef Al-Said
Journal:  Int J Surg Case Rep       Date:  2019-04-28

6.  Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome.

Authors:  Thomas Nelson; Jethro Hu; Serguei Bannykh; Xuemo Fan; Jeremy Rudnick; Eric Vail
Journal:  CNS Oncol       Date:  2020-03-06

7.  Transcanal endoscopic assisted skull base endolymphatic sac tumor resection: A rare disease with advanced technology.

Authors:  Wai Tsz Chang; Ka Yue Tam; Hung Yao; Kwan Ho Chow; Michael Chi Fai Tong
Journal:  J Otol       Date:  2019-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.